These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7125366)

  • 1. Bacteremia caused by Streptococcus pneumoniae of nonvaccine serotypes.
    Shlaes DM; Mandell R; Bass S; Spagnuolo PJ
    Am Rev Respir Dis; 1982 Oct; 126(4):712-3. PubMed ID: 7125366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine.
    Jacobs MR; Good CE; Bajaksouzian S; Windau AR
    Clin Infect Dis; 2008 Dec; 47(11):1388-95. PubMed ID: 18959493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotypes of Streptococcus pneumoniae isolated from blood cultures at Boston City Hospital between 1979 and 1982.
    Barry MA; Craven DE; Finland M
    J Infect Dis; 1984 Mar; 149(3):449-52. PubMed ID: 6715901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotyping of 1,458 pneumococcal isolates with analysis of bacteremia in 84 patients.
    Fanciullo GJ; Baltch AL; Smith RP; Hollick G; Shayegani M
    South Med J; 1986 Nov; 79(11):1370-5. PubMed ID: 3775464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotypes of respiratory isolates of Streptococcus pneumoniae compared with the capsular types included in the current pneumococcal vaccine.
    Jorgenson JH; Howell AW; Maher LA; Facklam RR
    J Infect Dis; 1991 Mar; 163(3):644-6. PubMed ID: 1995737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of recent pneumococcal infections with attention to vaccine and nonvaccine serotypes.
    Hager HL; Woolley TW; Berk SL
    Rev Infect Dis; 1990; 12(2):267-72. PubMed ID: 2184495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ; Klugman KP; Pichichero M
    Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inferring the potential success of pneumococcal vaccination in Italy: serotypes and antibiotic resistance of Streptococcus pneumoniae isolates from invasive diseases.
    Pantosti A; Boccia D; D'Ambrosio F; Recchia S; Orefici G; Moro ML; ;
    Microb Drug Resist; 2003; 9 Suppl 1():S61-8. PubMed ID: 14633369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Emergence of invasive nonvaccine pneumococcal serotypes: 2 cases involving 19A and 10A serotypes].
    Ferré P; Daoud P; Zemouri N
    Arch Pediatr; 2009 Oct; 16(10):1350-2. PubMed ID: 19758792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.
    Hicks LA; Harrison LH; Flannery B; Hadler JL; Schaffner W; Craig AS; Jackson D; Thomas A; Beall B; Lynfield R; Reingold A; Farley MM; Whitney CG
    J Infect Dis; 2007 Nov; 196(9):1346-54. PubMed ID: 17922399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococcal serotypes causing bacteremia and meningitis: relevance to composition of pneumococcal vaccine.
    Dixon JM; Lipinski AE
    Can Med Assoc J; 1981 Aug; 125(3):263-7. PubMed ID: 7272879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New 23-valent pneumococcal vaccine in relation to pneumococcal serotypes in systemic and non-systemic disease.
    Smart LE; Dougall AJ; Girdwood RW
    J Infect; 1987 May; 14(3):209-15. PubMed ID: 3585032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM; Memish ZA; Al-Kattan KM
    Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation.
    dos Santos SR; Passadore LF; Takagi EH; Fujii CM; Yoshioka CR; Gilio AE; Martinez MB
    Vaccine; 2013 Dec; 31(51):6150-4. PubMed ID: 23747454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotype 19A is the most common Streptococcus pneumoniae isolate in children with chronic sinusitis.
    McNeil JC; Hulten KG; Mason EO; Kaplan SL
    Pediatr Infect Dis J; 2009 Sep; 28(9):766-8. PubMed ID: 19636285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Disribution of Streptococcus pneumoniae serotypes and serogroups among patients with invasive pneumococcal diseases in the Czech Republic in 1996-2003: background data for vaccination strategy].
    Motlová J
    Epidemiol Mikrobiol Imunol; 2005 Feb; 54(1):3-10. PubMed ID: 15807381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of underlying disease and age on pneumococcal serotype distribution.
    Weisholtz SJ; Hartman BJ; Roberts RB
    Am J Med; 1983 Aug; 75(2):199-205. PubMed ID: 6881171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.
    Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J
    Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.